Photoreceptor cell apoptosis induced by the 2-nitroimidazole radiosensitizer, CI-1010, is mediated by p53-linked activation of caspase-3.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16125243)

Published in Neurotoxicology on August 24, 2005

Authors

Terry J Miller1, Randal J Schneider, James A Miller, Brad P Martin, Muayyad R Al-Ubaidi, Neeraj Agarwal, Lloyd A Dethloff, Martin A Philbert

Author Affiliations

1: Toxicology Program, Department of Environmental Health Sciences, University of Michigan, 1420 Washington Heights, SPH II, Ann Arbor, MI 48109-2029, USA.

Articles by these authors

Safe handling of nanotechnology. Nature (2006) 7.25

Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma. J Clin Oncol (2012) 3.65

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol (2013) 3.19

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol (2012) 2.84

Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res (2006) 2.46

Bladder cancer. J Natl Compr Canc Netw (2013) 2.46

NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw (2009) 2.40

Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol (2007) 2.37

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial. Lancet Oncol (2013) 2.29

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J Clin Oncol (2014) 2.19

Enols are common intermediates in hydrocarbon oxidation. Science (2005) 2.15

Real-time measurements of dissolved oxygen inside live cells by organically modified silicate fluorescent nanosensors. Anal Chem (2004) 1.97

Hematopoiesis is not clonal in healthy elderly women. Blood (2008) 1.95

Socio-demographic correlates of breast-feeding in urban slums of Chandigarh. Indian J Med Sci (2006) 1.94

Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci (2004) 1.92

NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw (2009) 1.86

CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. Cancer Res (2010) 1.78

The new toxicology of sophisticated materials: nanotoxicology and beyond. Toxicol Sci (2010) 1.71

Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev (2006) 1.66

Radon, smoking, and lung cancer: the need to refocus radon control policy. Am J Public Health (2013) 1.65

Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol (2005) 1.56

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol (2009) 1.48

Kinase-dependent differentiation of a retinal ganglion cell precursor. Invest Ophthalmol Vis Sci (2006) 1.47

Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci (2005) 1.40

Repression of Six3 by a corepressor regulates rhodopsin expression. Proc Natl Acad Sci U S A (2007) 1.38

"Nanosized voltmeter" enables cellular-wide electric field mapping. Biophys J (2007) 1.37

Nanoparticles for two-photon photodynamic therapy in living cells. Nano Lett (2006) 1.37

Oxidative stress in glaucoma: a burden of evidence. J Glaucoma (2007) 1.36

Targeted expression of Cre recombinase to cone photoreceptors in transgenic mice. Mol Vis (2004) 1.31

Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci (2008) 1.30

Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells. Invest Ophthalmol Vis Sci (2007) 1.30

The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate. Brain Res Mol Brain Res (2004) 1.23

Multicolored stain-free histopathology with coherent Raman imaging. Lab Invest (2012) 1.22

Modeling the kinetics of bimolecular reactions. Chem Rev (2006) 1.20

Review of 2,4-dichlorophenoxyacetic acid (2,4-D) epidemiology and toxicology. Crit Rev Toxicol (2002) 1.19

Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors. Biophys J (2009) 1.18

G-protein-coupled receptor rhodopsin regulates the phosphorylation of retinal insulin receptor. J Biol Chem (2007) 1.17

Light induces programmed cell death by activating multiple independent proteases in a cone photoreceptor cell line. Invest Ophthalmol Vis Sci (2007) 1.13

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer (2013) 1.12

Retinal ganglion cell line apoptosis induced by hydrostatic pressure. Brain Res (2006) 1.12

Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. Invest Ophthalmol Vis Sci (2005) 1.11

Testicular cancer. J Natl Compr Canc Netw (2012) 1.11

Analysis of sigma receptor (sigmaR1) expression in retinal ganglion cells cultured under hyperglycemic conditions and in diabetic mice. Brain Res Mol Brain Res (2002) 1.10

Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest Ophthalmol Vis Sci (2003) 1.10

Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci (2013) 1.10

P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci (2003) 1.10

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci (2003) 1.09

Lack of protein-tyrosine sulfation disrupts photoreceptor outer segment morphogenesis, retinal function and retinal anatomy. Eur J Neurosci (2010) 1.08

Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem Biophys Res Commun (2008) 1.07

Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res (2006) 1.06

OPA1 expression in the normal rat retina and optic nerve. J Comp Neurol (2005) 1.06

Kidney cancer. J Natl Compr Canc Netw (2011) 1.06

Synchrotron photoionization measurements of combustion intermediates: photoionization efficiency and identification of C3H2 isomers. Phys Chem Chem Phys (2005) 1.04

Ratiometric optical PEBBLE nanosensors for real-time magnesium ion concentrations inside viable cells. Anal Chem (2003) 1.03

Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. Toxicol Appl Pharmacol (2010) 1.02

A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci (2007) 1.02

1,3-Dinitrobenzene inhibits mitochondrial complex II in rat and mouse brainstem and cortical astrocytes. Neurotoxicology (2003) 1.02

Soluble CD44 is cytotoxic to trabecular meshwork and retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci (2005) 1.02

Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem (2004) 1.01

Optochemical nanosensor PEBBLEs: photonic explorers for bioanalysis with biologically localized embedding. Curr Opin Chem Biol (2004) 1.01

In vitro characterization of a targeted, dye-loaded nanodevice for intraoperative tumor delineation. Neurosurgery (2009) 1.00

Retinal abnormalities associated with the G90D mutation in opsin. J Comp Neurol (2004) 1.00

Methylene blue-conjugated hydrogel nanoparticles and tumor-cell targeted photodynamic therapy. Macromol Biosci (2011) 1.00

Kidney cancer, version 2.2014. J Natl Compr Canc Netw (2014) 0.98

Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy. Appl Opt (2007) 0.98

Metabolic syndrome: a challenging health issue in highly urbanized Union Territory of north India. Diabetol Metab Syndr (2010) 0.97

Molecular characterization of the skate peripherin/rds gene: relationship to its orthologues and paralogues. Invest Ophthalmol Vis Sci (2003) 0.97

Metastatic potential of tumor-initiating cells in solid tumors. Front Biosci (Landmark Ed) (2011) 0.97

Hydrogel nanoparticles with covalently linked coomassie blue for brain tumor delineation visible to the surgeon. Small (2012) 0.97

Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97

Levels of fatigue and distress in senior prostate cancer survivors enrolled in a 12-week randomized controlled trial of Qigong. J Cancer Surviv (2013) 0.96

Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools. Breast Cancer Res Treat (2002) 0.96

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients. Target Oncol (2013) 0.95

Protein tyrosine-O-sulfation in bovine ocular tissues. Adv Exp Med Biol (2012) 0.95

The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents. Neurosurgery (2010) 0.95

Sequencing systemic therapies for metastatic kidney cancer. Curr Treat Options Oncol (2015) 0.95

Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci (2006) 0.93

Retinoid processing in cone and Müller cell lines. Exp Eye Res (2007) 0.93

Methylation of AR locus does not always reflect X chromosome inactivation state. Blood (2012) 0.93

The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5). Brain Res (2005) 0.92

Nanoscale probes encapsulated by biologically localized embedding (PEBBLEs) for ion sensing and imaging in live cells. Talanta (2004) 0.92

Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res (2005) 0.92

Heat shock protein 27 delays Ca2+-induced cell death in a caspase-dependent and -independent manner in rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2005) 0.91

Bioeliminable nanohydrogels for drug delivery. Nano Lett (2008) 0.91

Functional expression of cone cyclic nucleotide-gated channel in cone photoreceptor-derived 661W cells. Adv Exp Med Biol (2008) 0.91

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer. Clin Cancer Res (2013) 0.91

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma. Cancer (2014) 0.90

Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol (2007) 0.90

Empirically identified goals for the management of unexplained symptoms. Fam Med (2006) 0.90

Liquid polymer nano-PEBBLEs for Cl- analysis and biological applications. Analyst (2003) 0.90

Rhodopsin: the functional significance of asn-linked glycosylation and other post-translational modifications. Ophthalmic Genet (2009) 0.90

New technologies for nutrition research. J Nutr (2004) 0.89

Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Mol Vis (2007) 0.89

Photoreceptor cells constitutively express functional TLR4. J Neuroimmunol (2011) 0.89

Nanoencapsulation method for high selectivity sensing of hydrogen peroxide inside live cells. Anal Chem (2010) 0.89

Metabolic complications with the use of mTOR inhibitors for cancer therapy. Cancer Treat Rev (2013) 0.89

IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (2010) 0.88